- Home
- IMMP vs TSI Comparison
IMMP vs TSI Comparison
Compare IMMP & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- TSI
- Stock Information
- Founded
- IMMP 1987
- TSI 1987
- Country
- IMMP Australia
- TSI United States
- Employees
- IMMP N/A
- TSI N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- TSI Investment Managers
- Sector
- IMMP Health Care
- TSI Finance
- Exchange
- IMMP Nasdaq
- TSI Nasdaq
- Market Cap
- IMMP 211.1M
- TSI 234.6M
- IPO Year
- IMMP N/A
- TSI N/A
- Fundamental
- Price
- IMMP $1.78
- TSI $4.93
- Analyst Decision
- IMMP Buy
- TSI
- Analyst Count
- IMMP 1
- TSI 0
- Target Price
- IMMP $7.00
- TSI N/A
- AVG Volume (30 Days)
- IMMP 150.7K
- TSI 106.8K
- Earning Date
- IMMP 02-27-2025
- TSI 01-01-0001
- Dividend Yield
- IMMP N/A
- TSI 7.46%
- EPS Growth
- IMMP N/A
- TSI N/A
- EPS
- IMMP N/A
- TSI N/A
- Revenue
- IMMP $3,019,249.00
- TSI N/A
- Revenue This Year
- IMMP $50.37
- TSI N/A
- Revenue Next Year
- IMMP N/A
- TSI N/A
- P/E Ratio
- IMMP N/A
- TSI N/A
- Revenue Growth
- IMMP 24.11
- TSI N/A
- 52 Week Low
- IMMP $1.32
- TSI $4.48
- 52 Week High
- IMMP $2.86
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- IMMP 44.44
- TSI 54.86
- Support Level
- IMMP $1.88
- TSI $4.91
- Resistance Level
- IMMP $1.94
- TSI $4.97
- Average True Range (ATR)
- IMMP 0.12
- TSI 0.04
- MACD
- IMMP -0.03
- TSI 0.00
- Stochastic Oscillator
- IMMP 0.00
- TSI 63.64
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.